AIC
PLSE icon

AWM Investment Company’s Pulse Biosciences PLSE Stock Holding History

AWM Investment Company’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-67,000
Closed -$301K – 104
2016
Q2 		$301K Buy
+67,000
New +$288K 0.06% 88

Other funds holding PLSE

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TF
Trutina Financial Bellevue, Washington $76.7M AUM 19.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

AWM Investment Company's PLSE Position: Q3 2016 in Review

AWM Investment Company sold out of Pulse Biosciences (PLSE) in Q3 2016, closing a stake of 67,000 shares — an estimated $301K sold.

AWM Investment Company first reported a position in PLSE in Q2 2016 and held it in 1 quarter. The position peaked at $301K in Q2 2016. 13 funds tracked by Wall St. Rank hold PLSE as of Q3 2016.

  • AWM Investment Company reported no remaining Pulse Biosciences position as of Q3 2016 after selling out during the quarter.
  • AWM Investment Company sold 67,000 Pulse Biosciences shares in Q3 2016, an estimated $301K.
  • AWM Investment Company first reported a position in Pulse Biosciences in Q2 2016 and held it in 1 quarter.
  • AWM Investment Company's Pulse Biosciences position peaked at $301K in Q2 2016.
  • 13 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2016.

Based on AWM Investment Company's 13F filing for Q3 2016, filed 14 Nov 2016.